Rheumatic Heart Disease

"Rheumatic Heart Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Cardiac manifestation of systemic rheumatological conditions, such as RHEUMATIC FEVER. Rheumatic heart disease can involve any part the heart, most often the HEART VALVES and the ENDOCARDIUM.

Descriptor ID	D012214
MeSH Number(s)	C01.252.410.890.731.649 C14.280.874
Concept/Terms	Rheumatic Heart Disease Rheumatic Heart Disease Disease, Rheumatic Heart Diseases, Rheumatic Heart Heart Disease, Rheumatic Heart Diseases, Rheumatic Rheumatic Heart Diseases Bouillaud Disease Bouillaud Disease Disease, Bouillaud Bouillaud's Disease Bouillauds Disease Disease, Bouillaud's

Below are MeSH descriptors whose meaning is more general than "Rheumatic Heart Disease".

Diseases [C]
Bacterial Infections and Mycoses [C01]
Bacterial Infections [C01.252]
Gram-Positive Bacterial Infections [C01.252.410]
Streptococcal Infections [C01.252.410.890]
Rheumatic Fever [C01.252.410.890.731]
Rheumatic Heart Disease [C01.252.410.890.731.649]
Cardiovascular Diseases [C14]
Heart Diseases [C14.280]
Rheumatic Heart Disease [C14.280.874]

Below are MeSH descriptors whose meaning is more specific than "Rheumatic Heart Disease".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Rheumatic Heart Disease" by people in this website by year, and whether "Rheumatic Heart Disease" was a major or minor topic of these publications.

Bar chart showing 22 publications over 9 distinct years, with a maximum of 4 publications in 2016 and 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2016	3	1	4
2017	2	0	2
2018	0	1	1
2019	2	0	2
2020	2	0	2
2021	2	0	2
2022	2	0	2
2023	3	0	3
2024	4	0	4

Below are the most recent publications written about "Rheumatic Heart Disease" by people in Profiles.

Jones B, Marangou J, Yan J, Ralph A, Mitchell A, Kaethner A, Remenyi B, Wade V, Katzenellenbogen JM, Monteiro AF, Cannon JW, Howard NJ, Gilles M, Haynes E, Seixas H, Maurays J, Neave J, Pears C, Engelman D, Canuto K, Steer A, Unger H, Bailey M, Tanesi M, Amaral S, Neto H, Stewart M, Burgess P, Brown A, Currie BJ, Hillis G, Morris P, Simon D, Wheaton G, Williamson J, de Dassel J, Slota-Kan S, Carapetis J, English M, Nagraj S, Francis JR. NEARER SCAN (LENO BESIK) evaluation of a task-sharing echocardiographic active case finding programme for rheumatic heart disease in Australia and Timor-Leste: protocol for a hybrid type II effectiveness-implementation study. BMJ Open. 2024 10 18; 14(10):e083467.

View in: PubMed
Oliver J, Fualautoalasi-Lam L, Ferdinand A, Tiatia R, Jones B, Engelman D, Gibney KB, Steer AC. Living with rheumatic fever and rheumatic heart disease in Victoria, Australia: A qualitative study. PLoS Negl Trop Dis. 2024 Aug; 18(8):e0012038.

View in: PubMed
Rwebembera J, Ndagire E, Carvalho N, Webel AR, Sable C, Okello E, Sarnacki R, Spaziani AM, Mucunguzi A, Engelman D, Grobler A, Steer A, Beaton A. Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial). Am Heart J. 2024 Sep; 275:74-85.

View in: PubMed
Ojha U, Marshall DC, Salciccioli JD, Al-Khayatt BM, Hammond-Haley M, Goodall R, Borsky KL, Crowley CP, Shalhoub J, Hartley A. Temporal trend analysis of rheumatic heart disease burden in high-income countries between 1990 and 2019. Eur Heart J Qual Care Clin Outcomes. 2024 Mar 01; 10(2):108-120.

View in: PubMed
Nascimento BR, Nunes MCP, da Silva JLP, Steer A, Engelman D, Okello E, Rwebembera J, Zuhlke L, Mirabel M, Nakitto M, Sarnacki R, Ribeiro ALP, Sable CA, Beaton AZ. Outcomes of latent rheumatic heart disease: External validation of a simplified score in patients with and without secondary prophylaxis. Int J Cardiol. 2024 Mar 15; 399:131662.

View in: PubMed
Beaton A, Okello E, Rwebembera J, Grobler A, Engelman D, Alepere J, Carapetis J, DeWyer A, Lwabi P, Mirabel M, Mocumbi AO, Nakitto M, Ndagire E, Nunes MCP, Omara IO, Sarnacki R, Scheel A, Wilson N, Z?hlke L, Karthikeyan G, Sable CA, Steer AC. Refining Risk Stratification Among Children With Latent Rheumatic Heart Disease. Circulation. 2023 06 13; 147(24):1848-1850.

View in: PubMed
Parks T, Narube L, Perman ML, Sakumeni K, Fong JJ, Engelman D, Colquhoun SM, Steer AC, Kado J. Population-based assessment of cardiovascular complications of rheumatic heart disease in Fiji: a record-linkage analysis. BMJ Open. 2023 04 24; 13(4):e070629.

View in: PubMed
Lindholm DE, Whiteman IJ, Oliver J, Cheung MMH, Hope SA, Brizard CP, Horton AE, Sheridan B, Hardy M, Osowicki J, Steer AC, Engelman D. Acute rheumatic fever and rheumatic heart disease in children and adolescents in Victoria, Australia. J Paediatr Child Health. 2023 02; 59(2):352-359.

View in: PubMed
Rwebembera J, Beaton A, Okello E, Engelman D, Fall N, Mirabel M, Nakitto M, Pereira Nunes MC, Pulle J, Sarnacki R, Scheel A, Zuhlke L, Grobler A, Steer AC, Sable C. Comparison of approaches to determine echocardiographic outcomes for children with latent rheumatic heart disease. Open Heart. 2022 12; 9(2).

View in: PubMed
Beaton A, Okello E, Rwebembera J, Grobler A, Engelman D, Alepere J, Canales L, Carapetis J, DeWyer A, Lwabi P, Mirabel M, Mocumbi AO, Murali M, Nakitto M, Ndagire E, Nunes MCP, Omara IO, Sarnacki R, Scheel A, Wilson N, Zimmerman M, Z?hlke L, Karthikeyan G, Sable CA, Steer AC. Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease. N Engl J Med. 2022 01 20; 386(3):230-240.

View in: PubMed

People

Explore

Similar Concepts

Top Journals